REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmagal - Bio, Spol. S R.O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmagal - Bio, Spol. S R.O. Profile Updated: October 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pharmagal - Bio, Spol. S R.O. is an enterprise in Slovakia, with the main office in Nitra. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on June 18, 1998. 25 - 49 (2023) employees currently work for Pharmagal - Bio, Spol. S R.O.. There was a net sales revenue increase of 27.46% reported in Pharmagal - Bio, Spol. S R.O.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 40.5%. The net profit margin of Pharmagal - Bio, Spol. S R.O. increased by 10.37% in 2023.

Headquarters
Murgasova, 5
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Pharmagal - Bio, Spol. S R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmagal - Bio, Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Pharmagal - Bio, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Pharmagal - Bio, Spol. S R.O. report to view the information.
Incorporation Date:
June 18, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
26.8%
Purchase this report to view the information.
24.41%
Purchase this report to view the information.
24.4%
Purchase this report to view the information.
24.4%
Company Performance
Financial values in the chart are available after Pharmagal - Bio, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
27.46%
Total operating revenue
27.8%
Operating profit (EBIT)
52.59%
EBITDA
48.63%
Net Profit (Loss) for the Period
60.27%
Total assets
40.5%
Total equity
46.06%
Operating Profit Margin (ROS)
10.13%
Net Profit Margin
10.37%
Return on Equity (ROE)
3.23%
Debt to Equity Ratio
0.01%
Quick Ratio
1.3%
Cash Ratio
1.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?